Covalon Technologies
Michael Morozov, PhD, is a scientist with extensive experience in pharmaceutical and materials development. Current employment at Covalon Technologies Ltd. as a Scientist began in January 2022. Prior to this, Michael served as a Pharmaceutical Scientist at Covar Pharmaceuticals from September 2019 to December 2021, focusing on drug formulation and scale-up procedures. Experience also includes a Scientist role at Qvella Corporation from April 2018 to March 2019, where formulation development and optimization for blood sample testing were key responsibilities. Earlier, Michael worked as a Research Chemist at NanoAF, developing synthetic methods for antifouling applications. Academic credentials include a PhD and MSc in Organic Chemistry from the Weizmann Institute of Science and a BASc in Molecular Bio-Chemistry from the Technion - Israel Institute of Technology.
Covalon Technologies
Covalon Technologies Ltd. researches, develops, and commercializes new healthcare technologies that help save lives around the world. Covalon's patented technologies, products, and services address the advanced healthcare needs of medical device companies, healthcare providers, and individual consumers. Covalon's technologies are used to prevent, detect, and manage medical conditions in specialty areas such as infection control, vascular access, surgical procedures, advanced wound care, and medical device coatings.